Epistra Exhibited at the AMED 'SCARDA Joint Forum 2025'
Epistra, Inc. exhibited at the “SCARDA Joint Forum 2025 — Progress and Outcomes of Infectious Disease Vaccine Research: Toward Deeper Collaboration,” hosted by AMED (Japan Agency for Medical Research and Development) on Wednesday, November 26, 2025.
The forum was organized by AMED’s Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) as a venue for sharing research outcomes and progress on vaccines and novel modalities, with the aim of deepening collaboration among industry, academia, government, and venture capital.
The event brought together numerous researchers and business professionals both on-site and online, with active discussions taking place.
Related Articles
Won Grand Prix in the 7th IP BASE AWARD Startup Category Hosted by the Japan Patent Office
On March 3, 2026, Epistra Inc. won the Grand Prix in the startup category at the '7th IP BASE AWARD' ceremony hosted by the Japan Patent Office.
Jikkenigaku Special Issue 'AI and Data-Driven Drug Discovery Research' Published — CTO Tsuzuki Authors Chapter on AI-Driven Drug Target Discovery
In 'Jikkenigaku Special Issue: AI and Data-Driven Drug Discovery Research' published by Yodosha, our CTO Taku Tsuzuki authored a chapter on AI-driven knowledge mining for drug target discovery.
Speaking Engagement: Delivered Keynote at the 10th Cell Manufacturing Kotozukuri Symposium
On March 4, 2026, CEO Yosuke Ozawa delivered a keynote speech on optimizing cell manufacturing processes using AI and robotics at the '10th Cell Manufacturing Kotozukuri Symposium' hosted by Osaka University.